Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00516828
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2007-08-14
Brief Title:
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor:
NCIC Clinical Trials Group
Organization:
Canadian Cancer Trials Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with t1517q22q12 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |
| adult acute myeloid leukemia with t821q22q22 | View |
| untreated adult acute myeloid leukemia | View |
| secondary acute myeloid leukemia | View |
| de novo myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |